Fusion Pharmaceuticals Inc.

ORBIMED ADVISORS LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

3,122,770

Value ($000)

30,010

Weight

0.6%

2020 Q2 - 2023 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	30,010	0.6%	3,122,770	12/31/2023
2023 Q3	11/14/2023	8,119	0.2%	3,122,770	9/30/2023
2023 Q2	8/14/2023	14,583	0.3%	3,122,770	6/30/2023
2023 Q1	5/15/2023	11,773	0.2%	3,122,770	3/31/2023
2022 Q4	2/14/2023	10,158	0.2%	3,224,770	12/31/2022
2022 Q3	11/14/2022	9,707	0.2%	3,224,770	9/30/2022
2022 Q2	8/15/2022	8,030	0.1%	3,224,770	6/30/2022
2022 Q1	5/16/2022	25,056	0.4%	3,224,770	3/31/2022
2021 Q4	2/14/2022	13,447	0.2%	3,224,770	12/31/2021
2021 Q3	11/15/2021	25,540	0.3%	3,224,770	9/30/2021
2021 Q2	8/16/2021	26,056	0.3%	3,224,770	6/30/2021
2021 Q1	5/17/2021	34,570	0.3%	3,224,770	3/31/2021
2020 Q4	2/16/2021	37,891	0.3%	3,224,770	12/31/2020
2020 Q3	11/16/2020	38,762	0.5%	3,224,770	9/30/2020
2020 Q2	8/14/2020	56,337	0.8%	3,224,770	6/30/2020